SURAKSHA DIAGNOSTIC
|
SURAKSHA DIAGNOSTIC Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 342.41 | 94.43 | 344.20 | 93.26 | 220.48 |
| CEPS(Rs) | 807.61 | 546.90 | 562.91 | 320.97 | 403.02 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 2,576.51 | 2,236.19 | 2,149.92 | 1,805.72 | 1,712.46 |
| Tax Rate(%) | 26.47 | 10.12 | 28.45 | -0.96 | 27.61 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 32.41 | 23.37 | 21.54 | 16.15 | 21.65 |
| EBIT Margin(%) | 18.77 | 8.58 | 15.81 | 5.91 | 14.63 |
| Pre Tax Margin(%) | 14.38 | 3.55 | 14.87 | 4.55 | 13.34 |
| PAT Margin (%) | 10.57 | 3.19 | 10.64 | 4.60 | 9.66 |
| Cash Profit Margin (%) | 25.48 | 19.85 | 17.40 | 15.82 | 17.66 |
| Performance Ratios | |||||
| ROA(%) | 7.96 | 2.52 | 12.78 | 3.74 | 10.20 |
| ROE(%) | 13.93 | 4.01 | 17.40 | 5.30 | 17.73 |
| ROCE(%) | 22.94 | 9.62 | 22.65 | 6.04 | 20.19 |
| Asset Turnover(x) | 0.75 | 0.79 | 1.20 | 0.81 | 1.06 |
| Sales/Fixed Asset(x) | 0.87 | 0.87 | 1.09 | 0.71 | 1.02 |
| Working Capital/Sales(x) | 6.62 | 6.40 | -35.44 | 58.72 | -26.65 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.14 | 1.15 | 0.92 | 1.40 | 0.99 |
| Receivable days | 11.31 | 11.76 | 11.09 | 15.63 | 12.22 |
| Inventory Days | 10.71 | 11.89 | 8.72 | 12.89 | 10.81 |
| Payable days | 190.41 | 185.93 | 80.01 | 181.56 | 196.29 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | - | - |
| PCE(x) | - | - | - | - | - |
| Price/Book(x) | - | - | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | -0.17 | -0.17 | 0.11 | 0.15 | 0.10 |
| EV/Core EBITDA(x) | -0.51 | -0.68 | 0.49 | 0.86 | 0.45 |
| EV/EBIT(x) | -0.92 | -1.99 | 0.70 | 2.48 | 0.70 |
| EV/CE(x) | -0.20 | -0.19 | 0.15 | 0.14 | 0.12 |
| M Cap / Sales | - | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.03 | -14.81 | 59.42 | -11.11 | 58.87 |
| Core EBITDA Growth(%) | 55.14 | -4.78 | 110.05 | -32.70 | 53.35 |
| EBIT Growth(%) | 151.77 | -53.80 | 326.43 | -64.09 | 63.76 |
| PAT Growth(%) | 281.32 | -74.46 | 269.06 | -57.70 | 176.66 |
| EPS Growth(%) | 262.58 | -72.56 | 269.06 | -57.70 | 176.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.05 | 0.09 | 0.13 | 0.13 | 0.10 |
| Current Ratio(x) | 1.84 | 1.77 | 0.78 | 1.10 | 0.83 |
| Quick Ratio(x) | 1.67 | 1.61 | 0.55 | 0.92 | 0.67 |
| Interest Cover(x) | 4.27 | 1.71 | 16.78 | 4.35 | 11.33 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of SURAKSHA DIAGNOSTIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SURAKSHA DIAGNOSTIC | ₹1,455.7 Cr | 8.4% | 4.2% | NA | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹110,392.0 Cr | 3.5% | 14.9% | 36.6% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹96,641.3 Cr | 1.5% | 8.6% | 3.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹49,008.1 Cr | -7.1% | 1.4% | 54.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹34,289.7 Cr | -0.8% | 7.9% | 28.7% | Stock Analytics | |
| GLOBAL HEALTH | ₹33,119.5 Cr | 2.9% | 2% | -7.4% | Stock Analytics | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SURAKSHA DIAGNOSTIC | 8.4% |
4.2% |
|
| SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses
